tirzepatide and lamotrigine Lilly Shows Superiority in SURMOUNT-3 4 Compounded Tirzepatide - Weight Loss

PMID: 16412534

In addition to diabetes and obesity, GLP-1 drugs have been widely applied in clinical trials in various diseases, including fatty liver disease, cardiovascular disease, Alzheimer's disease, Parkinson's disease, and chronic kidney disease

As the data did not always follow a normal distribution, both methodologies were used to compare the splay of that data, with the reporting value being taken from the chi-squared test

The medication is administered as a once-weekly subcutaneous injection and is currently in phase 3 clinical trials, with FDA approval potentially on the horizon pending trial outcomes